Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Panacea Life Sciences's free cash flow for the twelve months ending Jun 30, 2023 was -$2.28M. For fiscal 2023 it was -$1.59M. The highest annual figure on record is -$405.67K in fiscal 2014.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$1.59M | – |
| FY2022 | Dec 31, 2022 | -$2.64M | – |
| FY2021 | Dec 31, 2021 | -$4.09M | – |
| FY2020 | Dec 31, 2020 | -$10.85M | – |
| FY2019 | Dec 31, 2019 | -$6.29M | – |
| FY2018 | Dec 31, 2018 | -$465.76K | – |
| FY2016 | Dec 31, 2016 | -$889.66K | – |
| FY2015 | Dec 31, 2015 | -$640.02K | – |
| FY2014 | Dec 31, 2014 | -$405.67K | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -$362.09K | – |
| Q2 FY2023 | Jun 30, 2023 | -$492.67K | – |
| Q1 FY2023 | Mar 31, 2023 | -$329.07K | – |
| Q4 FY2022 | Dec 31, 2022 | -$621.84K | – |
| Q3 FY2022 | Sep 30, 2022 | -$838.44K | – |
| Q2 FY2022 | Jun 30, 2022 | -$737.34K | – |
| Q1 FY2022 | Mar 31, 2022 | -$445.77K | – |
| Q4 FY2021 | Dec 31, 2021 | -$1.22M | – |
| Q3 FY2021 | Sep 30, 2021 | -$738.70K | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.24M | – |
| Q1 FY2021 | Mar 31, 2021 | -$882.00K | – |
| Q4 FY2020 | Dec 31, 2020 | -$925.80K | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.90M | – |
| Q2 FY2020 | Jun 30, 2020 | -$5.85M | – |
| Q1 FY2020 | Mar 31, 2020 | -$164.28K | – |
| Q4 FY2019 | Dec 31, 2019 | -$673.62K | – |
| Q3 FY2019 | Sep 30, 2019 | -$1.74M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.01M | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.86M | – |
| Q4 FY2018 | Dec 31, 2018 | -$57.83K | – |
| Q3 FY2018 | Sep 30, 2018 | -$73.92K | – |
| Q2 FY2018 | Jun 30, 2018 | -$38.73K | – |
| Q1 FY2018 | Mar 31, 2018 | -$295.28K | – |
| Q4 FY2016 | Dec 31, 2016 | -$406.82K | – |
| Q3 FY2016 | Sep 30, 2016 | -$129.28K | – |
| Q2 FY2016 | Jun 30, 2016 | -$187.03K | – |
| Q1 FY2016 | Mar 31, 2016 | -$166.54K | – |
| Q4 FY2015 | Dec 31, 2015 | -$69.14K | – |
| Q1 FY2015 | Mar 31, 2015 | -$82.68K | – |
| Q4 FY2014 | Dec 31, 2014 | -$291.04K | – |
| Q3 FY2014 | Sep 30, 2014 | -$15.13K | – |
See a number that looks wrong?